id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-N-0429-0002,FDA,FDA-2014-N-0429,"Class II Special Controls Guideline: Dengue Virus Serological
Reagents re Medical Devices; Immunology and Microbiology Devices; Classification of Dengue Virus Serological Reagents",Supporting & Related Material,Background Material,2014-05-30T04:00:00Z,2014,5,,,2014-05-30T19:20:20Z,,0,0,090000648171fbc6
FDA-2014-N-0429-0001,FDA,FDA-2014-N-0429,"Medical Devices; Immunology and Microbiology Devices; Classification of
Dengue Virus Serological Reagents",Rule,Final Rule,2014-05-30T04:00:00Z,2014,5,2014-05-30T04:00:00Z,,2014-05-30T14:48:44Z,2014-12545,0,0,090000648171f1e5